Find Reports

Select Report Type

Reimbursement Review

Displaying 551 - 575 of 1426

Please scroll or swipe to the right to view the full content.

Title	Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Recommendation Date Sort ascending	Project Number
Bavencio for metastatic Merkel...	Bavencio	Avelumab	AvelumabBavencio_metastaticMerkelcellcarcinoma10124_ProvFunding2019-11-19.pdf pcodr_avelumab_bavencio_mcc_fn_rec.pdf pcodr_avelumab_bavencio_mcc_fn_cgr.pdf pcodr_avelumab_bavencio_mcc_fn_egr.pdf pcodr_avelumab_bavencio_mmcc_in_rec.pdf pcodr_avelumab_bavencio_mcc_pagfdk.pdf pcodr_avelumab_bavencio_mcc_espa.pdf pcodr_avelumab_bavencio_mcc_clnfdk.pdf pcodr_avelumab_bavencio_mcc_coi_pt.pdf pcodr_avelumab_bavencio_mcc_coi_cln.pdf	metastatic Merkel Cell Carcinoma (mMCC)	Reimburse with clinical criteria and/or conditions	Complete	Oct 10, 2017	Mar 21, 2018	PC0124-000
Venclexta for Chronic Lymphocy...	Venclexta	Venetoclax	pcodr_profund_venetoclax_venclexta_cll.pdf pcodr_venetoclax_venclexta_cll_fn_rec.pdf pcodr_venetoclax_venclexta_cll_fn_cgr.pdf pcodr_venetoclax_venclexta_cll_fn_egr.pdf pcodr_venetoclax_venclexta_cll_in_rec.pdf pcodr_venetoclax_venclexta_cll_pagfdk.pdf pcodr_venetoclax_venclexta_cll_fdk_abbvie.pdf pcodr_venetoclax_venclexta_cll_ptfdk.pdf pcodr_venetoclax_venclexta_cll_clnfdk.pdf pcodr_venetoclax_venclexta_cll_coi_pt.pdf pcodr_venetoclax_venclexta_cll_coi_cln.pdf	Chronic Lymphocytic Leukemia	Reimburse with clinical criteria and/or conditions	Complete	Jul 10, 2017	Mar 2, 2018	PC0105-000
Keytruda for Metastatic Urothe...	Keytruda	Pembrolizumab	pcodr_provfund_pembrolizumab_keytruda_MUC.pdf pcodr_pembrolizumab_keytruda_muc_fn_rec.pdf pcodr_pembrolizumab_keytruda_muc_fn_cgr.pdf pcodr_pembrolizumab_keytruda_muc_fn_egr.pdf pcodr_pembrolizumab_keytruda_muc_in_rec.pdf pcodr_pembrolizumab_keytruda_muc_pagfdk.pdf pcodr_pembrolizumab_keytruda_muc_fdk_merck.pdf pcodr_pembrolizumab_keytruda_muc_clnfdk.pdf pcodr_pembrolizumab_keytruda_muc_coi_pt.pdf pcodr_pembrolizumab_keytruda_muc_coi_cln.pdf	For locally advanced or metastatic urothelial carcinoma	Reimburse with clinical criteria and/or conditions	Complete	Jul 24, 2017	Mar 2, 2018	PC0117-000
guselkumab	Tremfya	guselkumab	TS0001-PsO-Updated-Streamlined-Rec.pdf SR0530_Tremfya_complete_Feb-23-18.pdf SR0530_Tremfya_CL_Report.pdf SR0530_Tremfya_PE_Report.pdf SR0530_Tremfya_PI_Submissions.pdf	Psoriasis, moderate to severe plaque	Reimburse with clinical criteria and/or conditions	Complete	Aug 25, 2017	Feb 21, 2018	SR0530-000
nitisinone	Orfadin	nitisinone	SR0531_Orfadin_complete_Feb-23-18.pdf SR0531_Orfadin_CL_Report.pdf SR0531_Orfadin_PE_Report.pdf SR0531_Orfadin_PI.pdf	Hereditary tyrosinemia type 1	Reimburse with clinical criteria and/or conditions	Complete	Aug 29, 2017	Feb 21, 2018	SR0531-000
Adcetris for Hodgkin’s Lymphom...	Adcetris	Brentuximab Vedotin	pcodr_profund_brentuximab_adcetris_hl_post-asct_resub.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_fn_rec.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_fn_cgr.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_fn_egr.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_in_rec.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_pagfdk.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_fdk_sgi.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_clnfdk.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_coi_pt.pdf pcodr_brentuximab_adcetris_hl_post-asct_resub_coi_cln.pdf	HL at high risk of relapse or progression post-ASCT	Reimburse with clinical criteria and/or conditions	Complete	Aug 10, 2017	Feb 21, 2018	PC0116-000
infliximab	Renflexis	infliximab	TS0001-PsO-Updated-Streamlined-Rec.pdf SE0532 Renflexis - CDEC Final Recommendation February 20, 2018(redacted)_for posting.pdf SE0532_Renflexis_Combined_Report.pdf SE0532_Renflexis_PI.pdf	rheumatoid arthritis, ankylosing spondylitis, adult Crohn’s disease, pediatric Crohn’s disease, fistulising Crohn’s disease, adult ulcerative colitis, pediatric ulcerative colitis, psoriatic arthritis, plaque psoriasis	Reimburse with clinical criteria and/or conditions	Complete	Sep 5, 2017	Feb 20, 2018	SE0532-000
Faslodex for Locally Advanced ...	Faslodex	Fulvestrant	pcodr_provfund_fulvestrant_faslodex_mbc.pdf pcodr_fulvestrant_faslodex_mbc_fn_rec.pdf pcodr_fulvestrant_faslodex_mbc_fn_cgr.pdf pcodr_fulvestrant_faslodex_mbc_fn_egr.pdf pcodr_fulvestrant_faslodex_mbc_in_rec.pdf pcodr_fulvestrant_faslodex_mbc_pagfdk.pdf pcodr_fulvestrant_faslodex_mbc_fdk_asz.pdf pcodr_fulvestrant_faslodex_mbc_ptfdk.pdf pcodr_fulvestrant_faslodex_mbc_clnfdk.pdf pcodr_fulvestrant_faslodex_mbc_coi_pt.pdf pcodr_fulvestrant_faslodex_mbc_coi_cln.pdf	Locally advanced or metastatic breast cancer	Reimburse with clinical criteria and/or conditions	Complete	Jul 17, 2017	Feb 1, 2018	PC0110-000
migalastat	Galafold	migalastat	SR0522_Galafold_complete_Jan-26-18.pdf SR0522_Galafold_CL_Report.pdf SR0522_Galafold_PE_Report.pdf SR0522_Galafold_Patient_Input.pdf	Fabry Disease	Reimburse with clinical criteria and/or conditions	Complete	Jun 9, 2017	Jan 24, 2018	SR0522-000
cysteamine bitartrate	Procysbi	cysteamine bitartrate	SR0526_Procysbi_complete_Jan-26-18.pdf SR0526_Procysbi_CL_Report.pdf SR0526_Procysbi_PE_Report.pdf SR0526_Procysbi_Patient_Input.pdf SI0002-procysbi-drug-implementation-advice.pdf	Nephropathic cystinosis	Reimburse with clinical criteria and/or conditions	Complete	Aug 8, 2017	Jan 24, 2018	SR0526-000
glecaprevir pibrentasvir	Maviret	glecaprevir pibrentasvir	SR0523_Maviret_complete-Jan-25-18.pdf SR0523_Maviret_CL_Report.pdf SR0523_Maviret_PE_Report.pdf SR0523_Maviret_Patient_Input.pdf	Hepatitis C, chronic	Reimburse with clinical criteria and/or conditions	Complete	Jun 9, 2017	Jan 23, 2018	SR0523-000
Apomorphine	Movapo	apomorphine hydrochloride	SR0527_Movapo_complete-Jan-25-18.pdf SR0527_Movapo_CL_Report.pdf SR0527_Movapo_PE_Report.pdf SR0527_Movapo_Patient_Input.pdf	Parkinson's disease	Reimburse with clinical criteria and/or conditions	Complete	Jul 6, 2017	Jan 23, 2018	SR0527-000
sofosbuvir velpatasvir voxilap...	Vosevi	sofosbuvir velpatasvir voxilaprevir	SR0529_Vosevi_complete_Jan-25-18.pdf SR0529_Vosevi_CL_Report.pdf SR0529_Vosevi_PE_Report.pdf SR0529 Vosevi_Patient_Input.pdf	Hepatitis C, chronic	Reimburse with clinical criteria and/or conditions	Complete	Jul 28, 2017	Jan 23, 2018	SR0529-000
Onivyde for Metastatic Pancrea...	Onivyde	Irinotecan Liposome	pcodr_provfund_irinotecan_liposome_onivyde_mpc.pdf pcodr_irinotecan_liposome_onivyde_mpc_fn_rec.pdf pcodr_irinotecan_liposome_onivyde_mpc_fn_cgr.pdf pcodr_irinotecan_liposome_onivyde_mpc_fn_egr.pdf pcodr_irinotecan_liposome_onivyde_mpc_in_rec.pdf pcodr_irinotecan_liposome_onivyde_mpc_pagfdk.pdf pcodr_irinotecan_liposome_onivyde_mpc_clnfdk.pdf pcodr_irinotecan_liposome_onivyde_mpc_coi_pt.pdf pcodr_irinotecan_liposome_onivyde_mpc_coi_cln.pdf	Metastatic Pancreatic Cancer	Reimburse with clinical criteria and/or conditions	Complete	Apr 27, 2017	Jan 5, 2018	PC0107-000
Pembrolizumab (Keytruda) class...	Keytruda	Pembrolizumab	pcodr_profund_pembrolizumab_keytruda_chl.pdf pcodr_pembrolizumab_keytruda_chl_fn_rec.pdf pcodr_pembrolizumab_keytruda_chl_fn_cgr.pdf pcodr_pembrolizumab_keytruda_chl_fn_egr.pdf pcodr_pembrolizumab_keytruda_chl_in_rec.pdf pcodr_pembrolizumab_keytruda_chl_pagfdk.pdf pcodr_pembrolizumab_keytruda_chl_fdk_merck.pdf pcodr_pembrolizumab_keytruda_chl_ptfdk.pdf pcodr_pembrolizumab_keytruda_chl_clnfdk.pdf pcodr_pembrolizumab_keytruda_chl_coi_pt.pdf pcodr_pembrolizumab_keytruda_chl_coi_cln.pdf	classical Hodgkin Lymphoma (cHL)	Reimburse with clinical criteria and/or conditions	Complete	Jul 7, 2017	Jan 5, 2018	PC0109-000
nusinersen	Spinraza	nusinersen	SR0525_Spinraza_complete_Dec_22_17.pdf SR0525_Spinraza_CL_Report.pdf SR0525_Spinraza_PE_Report.pdf SR0525_Spinraza_Patient_Input.pdf	Spinal Muscular Atrophy	Reimburse with clinical criteria and/or conditions	Complete	Jun 28, 2017	Dec 22, 2017	SR0525-000
Rydapt for Acute Myeloid Leuke...	Rydapt	Midostaurin	pcodr_profund_midostaurin_rydapt_aml.pdf pcodr_midostaurin_rydapt_all_fn_rec.pdf pcodr_midostaurin_rydapt_all_fn_cgr.pdf pcodr_midostaurin_rydapt_all_fn_egr.pdf pcodr_midostaurin_rydapt_all_in_rec.pdf pcodr_midostaurin_rydapt_all_pagfdk.pdf pcodr_midostaurin_rydapt_all_fdk_novartis.pdf pcodr_midostaurin_rydapt_all_clnfdk.pdf pcodr_midostaurin_rydapt_all_coi_pt.pdf pcodr_midostaurin_rydapt_all_coi_cln.pdf	Acute Myeloid Leukemia	Reimburse	Complete	Jun 12, 2017	Dec 19, 2017	PC0108-000
Opdivo in combo with Yervoy fo...	Opdivo & Yervoy in combo	Nivolumab & Ipilimumab in combo	pcodr_profund_opdivo_yervoy_metmela.pdf pcodr_opdivo_yervoy_metmela_fn_rec.pdf pcodr_opdivo_yervoy_metmela_fn_cgr.pdf pcodr_opdivo_yervoy_metmela_fn_egr.pdf pcodr_opdivo_yervoy_metmela_in_rec.pdf pcodr_opdivo_yervoy_metmela_pagfdk.pdf pcodr_opdivo_yervoy_metmela_fdk_bms.pdf pcodr_opdivo_yervoy_metmela_ptfdk_mnc.pdf pcodr_opdivo_yervoy_metmela_ptfdk_sys.pdf pcodr_opdivo_yervoy_metmela_clfdk.pdf pcodr_opdivo_yervoy_metmela_coi_pt.pdf pcodr_opdivo_yervoy_metmela_coi_cl.pdf	Metastatic Melanoma	Reimburse with clinical criteria and/or conditions	Complete	Nov 30, 2016	Nov 30, 2017	PC0098-000
lixisenatide	Adlyxine	lixisenatide	SR0520_Adlyxine_complete_Nov-23-17.pdf SR0520_Adlyxine_CL_Report.pdf SR0520_Adlyxine_PE_Report.pdf SR0520_Adlyxine_PI_Submissions.pdf	Diabetes mellitus, Type 2	Reimburse with clinical criteria and/or conditions	Complete	May 29, 2017	Nov 23, 2017	SR0520-000
Brexpiprazole	Rexulti	Brexpiprazole	cdr_SR0514_TBC.pdf SR0514_Rexulti_complete_Nov_24_17.pdf SR0514_Rexulti_CL_Report.pdf SR0514_Rexulti_PE_Report.pdf SR0514_Rexulti_PI_Submissions.pdf	schizophrenia	Reimburse with clinical criteria and/or conditions	Complete	Feb 3, 2017	Nov 22, 2017	SR0514-000
Evolocumab	Repatha	Evolocumab	cdr_SR0515_Repatha.pdf SR0515_Repatha_Resubmission_complete_Nov_24_17.pdf SR0515_Repatha_Resubmission_CL_Report.pdf SR0515_Repatha_Resubmission_PE_Report.pdf SR0515_Repatha_PI_Submissions.pdf	Primary hyperlipidemia and mixed dyslipidemia	Reimburse with clinical criteria and/or conditions	Complete	Feb 17, 2017	Nov 22, 2017	SR0515-000
ulipristal acetate	Fibristal	ulipristal acetate	SF0528_Fibristal_RFA_complete_Nov_22_17.pdf SF0528_Fibristal_RFA_Report.pdf SF0528_Fibristal_PI_Submissions.pdf	Uterine fibroids (signs and symptoms)	Reimburse with clinical criteria and/or conditions	Complete	Jun 21, 2017	Nov 22, 2017	SF0528-000
ocrelizumab	Ocrevus	ocrelizumab	SR0519_Ocrevus_RMS_complete_Nov-23-17.pdf SR0519_Ocrevus_RMS _PE_Report.pdf SR0519_Ocrevus_RMS_CL_Report.pdf SR0519_Ocrevus_RMS_PI_Submissions.pdf	multiple sclerosis, relapsing	Reimburse with clinical criteria and/or conditions	Complete	May 16, 2017	Nov 21, 2017	SR0519-000
insulin degludec	Tresiba	insulin degludec	SR0521_Tresiba_complete_Nov-22-17_e.pdf SR0521_Tresiba_CL_Report.pdf SR0521_Tresiba_PE_Report.pdf SR0521_Tresiba_PI_Submissions.pdf	Diabetes mellitus, Type 1 & 2	Reimburse with clinical criteria and/or conditions	Complete	May 31, 2017	Nov 20, 2017	SR0521-000
Tafinlar & Mekinist in com...	Tafinlar & Mekinist in combo	Dabrafenib & Trametinib in combo	pcodr_provfund_tafinlar_mekinist_nsclc.pdf pcodr_tafinlar_mekinist_nsclc_fn_rec.pdf pcodr_tafinlar_mekinist_nsclc_fn_cgr.pdf pcodr_tafinlar_mekinist_nsclc_fn_egr.pdf pcodr_tafinlar_mekinist_nsclc_in_rec.pdf pcodr_tafinlar_mekinist_nsclc_pagfdk.pdf pcodr_tafinlar_mekinist_nsclc_fdk_novartis.pdf pcodr_tafinlar_mekinist_nsclc_ptfdk.pdf pcodr_tafinlar_mekinist_nsclc_clfdk.pdf pcodr_tafinlar_mekinist_nsclc_coi-cl.pdf pcodr_tafinlar_mekinist_nsclc_coi-pt.pdf	Non-Small Cell Lung Cancer	Do not reimburse	Complete	Mar 31, 2017	Nov 2, 2017	PC0106-000

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 551 - 575 of 602

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Sub Line	Status	Project Number
Drug Therapies for the Long-Term Prophylaxis of Hereditary Angioedema Attacks	ob0007-hae-prophylaxis-redacted.pdf	Dec 19, 2019		Completed	OB0007-000
Pilocarpine for Medication-induced Dry Mouth and Dry Eyes: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines	RC1225 Pilocarpine for MIX Final.pdf	Dec 11, 2019	Summary with Critical Appraisal		RC1225-000
Screening and Treatment of Obstetric Anemia: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines	RC1216 - Screening and treatment of obstetric anemia Final.pdf	Dec 6, 2019	Summary with Critical Appraisal	Completed	RC1216-000
Biopsy for Adults with Suspected Skin Cancer: A Rapid Qualitative Review	Biopsy for Adults with Suspected Skin Cancer: A Rapid Qualitative Review	Nov 21, 2019	Rapid Review	Completed	RC1215-000
Dosing and Timing of Immuno-Oncology Drugs	ho0008-dosing-timing-immuno-oncology-drugs.pdf	Nov 21, 2019	Technology Review	Completed	HO0008-000
Prostatectomy for People with Prostate Cancer: A Rapid Qualitative Review	Prostatectomy for People with Prostate Cancer: A Rapid Qualitative Review	Nov 12, 2019	Summary with Critical Appraisal	Completed	RC1209-000
Genome-Wide Sequencing: Ethical Considerations	he0020-genonme-wide-sequencing-protocol.pdf he0020-genome-wide-sequencing-ethical-considerations.pdf	Nov 12, 2019	Technology Review	Completed	HE0020-000
Healthy Aging		Oct 31, 2019			ES0342-000
Screening and Diagnostic Services for People at Risk of Breast Cancer: A Rapid Qualitative Review	Screening and Diagnostic Services for People at Risk of Breast Cancer: A Rapid …	Oct 31, 2019	Rapid Review	Completed	RC1208-000
Hemin for Injection (Panhematin): Budget Impact Analysis	ob0006_porphyria-report-redacted-final.pdf	Oct 16, 2019		Completed	OB0006-000
Second-Line Therapy for Patients with Relapsing-Remitting Multiple Sclerosis: A Review of Guidelines	RC1190 RRMS Second-line therapy Final.pdf	Sep 26, 2019	Summary with Critical Appraisal		RC1190-000
Collaboration in Health Technology Assessment in Canada: An Environmental Scan		Sep 13, 2019	Environmental Scan	Completed	ES0329-000
Hemlibra (Emicizumab): Economic Review Report	ob0005-emicizumab-eeconomic-report.pdf	Sep 11, 2019		Completed	OB0005-000
Collaboration in Health Technology Assessment in Canada		Sep 6, 2019	Environmental Scan	Completed	ES0329-000
Axicabtagene Ciloleucel for Adults With Relapsed or Refractory Large B-cell Lymphoma		Aug 15, 2019	Optimal Use	Completed	CT0002-000
Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Recommendations		Aug 15, 2019		Completed	CT0002-000
Buprenorphine-Naloxone Tablet Versus Methadone for the Treatment of Patients with Opioid Use Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines	RC1150 Suboxone vs.pdf	Jul 31, 2019	Summary with Critical Appraisal	Completed	RC1150-000
Appropriate Pharmacotherapy for Inflammatory Bowel Disease	ho0003-he0018-ibd-ou360.pdf	Jun 6, 2019	Technology Review	Completed	HO0003-000 - HE0018-000
Appropriate Pharmacotherapy for Inflammatory Bowel Disease		Jun 5, 2019	Technology Review	Completed	HO0003-000 - HE0018-000
Criteria for conducting Environmental Assessments in CADTH HTAs		Jun 5, 2019		In Progress	MG0017-000
Buprenorphine for Opioid Use Disorders during Pregnancy: A Review of Comparative Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines	RC1111 Buprenorphine for Opioid Use Disorder During Pregnancy Final.pdf	May 9, 2019	Summary with Critical Appraisal	Completed	RC1111-000
Rural Breast Cancer Surgery Programs: A Rapid Qualitative Review	Rural Breast Cancer Surgery Programs: A Rapid Qualitative Review	May 3, 2019	Rapid Review	Completed	RC1104-000
Prescription Drug Monitoring Programs: A Rapid Qualitative Review	Prescription Drug Monitoring Programs: A Rapid Qualitative Review	Apr 30, 2019	Rapid Review	Completed	RC1097-000
Buprenorphine for Opioid Use Disorder: A Review of Comparative Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines	RC1092 Buprenorphine for OUD Final.pdf	Apr 24, 2019	Summary with Critical Appraisal	Completed	RC1092-000
Gene Expression Profiling Tests for Breast Cancer: A Rapid Qualitative Review	Gene Expression Profiling Tests for Breast Cancer: A Rapid Qualitative Review	Apr 18, 2019	Summary with Critical Appraisal	Completed	RC1099-000

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 551 - 575 of 2138

Please scroll or swipe to the right to view the full content.

Title	Description	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
Chronic Lymphocytic Leukemia		Final Report	Oct 27, 2023	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0035-000
Prostate Cancer		Final Report	Oct 27, 2023	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0034-000
ravulizumab		Recommendation and Reasons Clinical, Pharmacoeconomic and Ethics combined Report Stakeholder feedback on Draft Recommendation	Oct 27, 2023	Reimbursement Review		Complete	SR0765-000
Hyperbaric Oxygen Therapy: An Emerging Therapy for Post–COVID-19 Condition	CADTH’s Horizon Scan examines hyperbaric oxygen therapy as a treatment to help resolve prominent symptoms of post-COVID-19 condition, such as fatigue and brain fog.	Hyperbaric Oxygen Therapy: An Emerging Therapy for Post–COVID-19 Condition	Oct 27, 2023	Horizon Scan	Health Technology Update	Completed	EN0050-000
Refractive Laser Surgery for Vision Conditions		Refractive Laser Surgery for Vision Conditions	Oct 26, 2023	Health Technology Review	Rapid Review	Completed	RC1514-000
New and Emerging Interventions to Alleviate Emergency Department Overcrowding	CADTH's Horizon Scan captures more than 80 new and emerging interventions to alleviate emergency department overcrowding. The interventions are organized into 5 broad categories of factors that contribute to emergency department overcrowding.	New and Emerging Interventions to Alleviate Emergency Department Overcrowding	Oct 25, 2023	Horizon Scan	Health Technology Update	Completed	EN0051-000
deucravacitinib		Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Oct 25, 2023	Reimbursement Review		Complete	SR0756-000
brentuximab vedotin			Oct 25, 2023	Reimbursement Review		Withdrawn	PC0311-000
avacopan		Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Oct 20, 2023	Reimbursement Review		Complete	SR0732-000
Cost-Effectiveness of Nirsevimab for Prevention of Respiratory Syncytial Virus Outcomes in Infants		Cost-Effectiveness of Nirsevimab for Prevention of Respiratory Syncytial Virus …	Oct 19, 2023	Health Technology Review	Technology Review	Completed	HE0045-000
Semaglutide 2 mg for Type 2 Diabetes		Semaglutide 2 mg for Type 2 Diabetes	Oct 19, 2023	Health Technology Review	Rapid Review	Completed	RC1507-000
Point of Care Ultrasound for Guided Central Venous Catheter Insertion		Point of Care Ultrasound for Guided Central Venous Catheter Insertion	Oct 16, 2023	Health Technology Review	Rapid Review	Completed	RC1509-000
Post–COVID-19 Condition Treatment and Management: Rapid Living Scoping Review			Oct 12, 2023	Health Technology Review	Scoping Review	Living Review	RE0040-000/RE0040-004
Radiofrequency Ablation for Chronic Knee, Hip, and Shoulder Pain		Radiofrequency Ablation for Chronic Knee, Hip, and Shoulder Pain	Oct 11, 2023	Health Technology Review	Rapid Review	Completed	RC1504-000
IV Acetaminophen for Acute Pain in Emergency Departments		IV Acetaminophen for Acute Pain in Emergency Departments	Oct 6, 2023	Health Technology Review	Rapid Review	Completed	RC1508-000
Perspectives and Experiences Regarding the Impacts of Emergency Department Overcrowding		Perspectives and Experiences Regarding the Impacts of Emergency Department Over…	Sep 28, 2023	Health Technology Review	Technology Review	Completed	HC0067-000
CADTH Pharmaceutical Reviews Update — Issue 41			Sep 28, 2023	Reimbursement Review	Pharmaceutical Review Update
rimegepant			Sep 27, 2023	Reimbursement Review		Withdrawn	SR0797-000
Optimizing the Use of Iodinated Contrast Media: Conservation Strategies Used Across Canada During the 2022 Shortage		CM0001-ICM-Conservation-Strategies.pdf	Sep 20, 2023	Health Technology Review	CMII Service	Completed	CM0001-000
Direct-Acting Antivirals for Pediatric Chronic Hepatitis C Virus Infection		Direct-Acting Antivirals for Pediatric Chronic Hepatitis C Virus Infection	Sep 20, 2023	Health Technology Review	Rapid Review	Completed	RC1502-000
Midline and Extended Dwell Catheters for IV Antibiotics		Midline and Extended Dwell Catheters for IV Antibiotics	Sep 18, 2023	Health Technology Review	Rapid Review	Completed	RC1505-000
Non-Sterile Glove Use		Non-Sterile Glove Use	Sep 15, 2023	Health Technology Review	Rapid Review	Completed	RC1499-000
Somatropin for Short Stature		Somatropin for Short Stature	Sep 15, 2023	Health Technology Review	Rapid Review	Completed	RC1501-000
trastuzumab deruxtecan		Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Sep 15, 2023	Reimbursement Review		Complete	PC0305-000
Remdesivir (Veklury) for the Treatment of COVID-19 in the Inpatient Setting		Summary Report — September 2023 Systematic Review — September 2023	Sep 13, 2023	Health Technology Review	Systematic Review	Completed	RE0048-000

Provisional Funding Algorithm

Displaying 76 - 81 of 81